Two centuries. Countless innovations. One vision.
Leadership & Vision
Clinical trial diversity is our responsibility
Learn more
Maintaining trust in science is crucial to public health. Here’s how the biopharma industry can help
A data and digital transformation: driving value and innovation
Takeda breaks ground on new treatment manufacturing facility in Thousand Oaks, California, USA
New report: The impact of plasma-derived therapies in Europe
Takeda Breaks Ground on Commercial Cell Therapy Manufacturing Facility in Lexington, Massachusetts
Guided by Our Values: Supporting Global COVID-19 Response
A ‘Swiss Cheese’ Approach Can Give Us a Second Chance to Contain COVID-19
COVID-19: Working Together to Go Faster for Patients
Coronavirus: Adjusting Our Business Approach While Serving Our Patients
Rajeev Venkayya, President, Global Vaccine Business Unit on the Latest on the Coronavirus and Takeda
Shaping the Future of Healthcare: Sustainability and Davos 2020
Takeda CEO Sees a Bright Future in Globalized Pharmaceuticals Market
Grand Opening of New Dengue Vaccine Manufacturing Plant in Singen, Germany
Grand Opening of Takeda’s New Production Facility, Grange Castle, Ireland
Takeda Breaks Ground on a State-of-the-Art Facility in Osaka, Japan
Strengthening Takeda’s Global Reach by Sustaining Core Values
CEO Christophe Weber on Why Takeda’s Unique Corporate Governance Structure Works
Ramona Sequeira, President of Takeda's U.S. Business Unit, on the Many Opportunities That Lie Ahead for the “New” Takeda
Celebrating Our New Global Reach
Takeda’s Transformation: The Next Chapter
Perspectives on Confronting and Embracing Disruptions in Healthcare
Strengthening Our Global Production Network in Oranienburg
Takeda Recognized for Commitment to Quality
